Bank of Montreal’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $230K | Sell |
27,428
-4
| -0% | -$33 | ﹤0.01% | 2919 |
|
|
2026
Q1 | $228K | Buy |
27,432
+4
| +0% | +$41 | ﹤0.01% | 2858 |
|
|
2025
Q4 | $339K | Hold |
27,428
| – | – | ﹤0.01% | 2516 |
|
|
2025
Q3 | $242K | Hold |
27,428
| – | – | ﹤0.01% | 2662 |
|
|
2025
Q2 | $175K | Sell |
27,428
-432
| -2% | -$2.47K | ﹤0.01% | 2852 |
|
|
2025
Q1 | $135K | Hold |
27,860
| – | – | ﹤0.01% | 2845 |
|
|
2024
Q4 | $266K | Buy |
27,860
+432
| +2% | +$3.96K | ﹤0.01% | 2610 |
|
|
2024
Q3 | $205K | Sell |
27,428
-9,893
| -27% | -$89.9K | ﹤0.01% | 3015 |
|
|
2024
Q2 | $258K | Buy |
37,321
+8,461
| +29% | +$36.4K | ﹤0.01% | 2836 |
|
|
2024
Q1 | $74.5K | Sell |
28,860
-51,225
| -64% | -$115K | ﹤0.01% | 3361 |
|
|
2023
Q4 | $198K | Sell |
80,085
-398,160
| -83% | -$936K | ﹤0.01% | 3143 |
|
|
2023
Q3 | $1.91M | Buy |
+478,245
| New | +$2.65M | ﹤0.01% | 1724 |
|
|
2022
Q2 | – | Sell |
-14,260
| Closed | -$597K | – | 4167 |
|
|
2022
Q1 | $597K | Sell |
14,260
-640
| -4% | -$28.2K | ﹤0.01% | 2702 |
|
|
2021
Q4 | $677K | Sell |
14,900
-234,918
| -94% | -$10.6M | ﹤0.01% | 2187 |
|
|
2021
Q3 | $13.1M | Buy |
249,818
+22,172
| +10% | +$1.34M | 0.01% | 1144 |
|
|
2021
Q2 | $14.6M | Buy |
227,646
+208,729
| +1,103% | +$13.4M | 0.01% | 1080 |
|
|
2021
Q1 | $1.49M | Sell |
18,917
-6,473
| -25% | -$663K | ﹤0.01% | 1931 |
|
|
2020
Q4 | $2.51M | Sell |
25,390
-50,425
| -67% | -$4.63M | ﹤0.01% | 1719 |
|
|
2020
Q3 | $8.44M | Sell |
75,815
-23,944
| -24% | -$2.58M | 0.01% | 926 |
|
|
2020
Q2 | $9.43M | Sell |
99,759
-13,682
| -12% | -$1.02M | 0.01% | 850 |
|
|
2020
Q1 | $6.47M | Buy |
113,441
+24,150
| +27% | +$1.39M | 0.01% | 875 |
|
|
2019
Q4 | $4.82M | Buy |
89,291
+26,598
| +42% | +$1.44M | ﹤0.01% | 1381 |
|
|
2019
Q3 | $3.28M | Buy |
62,693
+12,797
| +26% | +$596K | ﹤0.01% | 1389 |
|
|
2019
Q2 | $2.41M | Sell |
49,896
-24,561
| -33% | -$1.18M | ﹤0.01% | 1565 |
|
|
2019
Q1 | $3.76M | Sell |
74,457
-2,395
| -3% | -$141K | ﹤0.01% | 1325 |
|
|
2018
Q4 | $4.55M | Sell |
76,852
-11,505
| -13% | -$742K | ﹤0.01% | 1116 |
|
|
2018
Q3 | $5.82M | Buy |
88,357
+18,414
| +26% | +$1.07M | ﹤0.01% | 1110 |
|
|
2018
Q2 | $3.53M | Sell |
69,943
-23,883
| -25% | -$1.24M | ﹤0.01% | 1345 |
|
|
2018
Q1 | $4.94M | Sell |
93,826
-619
| -0.7% | -$30.9K | ﹤0.01% | 1151 |
|
|
2017
Q4 | $4.39M | Buy |
94,445
+3,163
| +3% | +$133K | ﹤0.01% | 1187 |
|
|
2017
Q3 | $3.69M | Buy |
91,282
+3,706
| +4% | +$134K | ﹤0.01% | 1297 |
|
|
2017
Q2 | $2.97M | Sell |
87,576
-25,622
| -23% | -$791K | ﹤0.01% | 1426 |
|
|
2017
Q1 | $3.29M | Buy |
113,198
+473
| +0.4% | +$14.4K | ﹤0.01% | 1264 |
|
|
2016
Q4 | $3.02M | Buy |
112,725
+57,197
| +103% | +$1.71M | ﹤0.01% | 1321 |
|
|
2016
Q3 | $1.75M | Sell |
55,528
-7,718
| -12% | -$224K | ﹤0.01% | 1570 |
|
|
2016
Q2 | $1.78M | Sell |
63,246
-3,334
| -5% | -$131K | ﹤0.01% | 1564 |
|
|
2016
Q1 | $2.42M | Sell |
66,580
-26,520
| -28% | -$937K | ﹤0.01% | 1348 |
|
|
2015
Q4 | $3.73M | Buy |
93,100
+72,266
| +347% | +$2.52M | ﹤0.01% | 1105 |
|
|
2015
Q3 | $593K | Sell |
20,834
-1,687
| -7% | -$55.6K | ﹤0.01% | 1782 |
|
|
2015
Q2 | $742K | Buy |
22,521
+792
| +4% | +$24.6K | ﹤0.01% | 1791 |
|
|
2015
Q1 | $625K | Sell |
21,729
-601
| -3% | -$17.2K | ﹤0.01% | 1826 |
|
|
2014
Q4 | $608K | Buy |
22,330
+161
| +0.7% | +$3.84K | ﹤0.01% | 1964 |
|
|
2014
Q3 | $472K | Sell |
22,169
-904
| -4% | -$20.7K | ﹤0.01% | 2102 |
|
|
2014
Q2 | $517K | Buy |
23,073
+7,165
| +45% | +$167K | ﹤0.01% | 2066 |
|
|
2014
Q1 | $401K | Buy |
15,908
+3,101
| +24% | +$78.3K | ﹤0.01% | 2171 |
|
|
2013
Q4 | $294K | Sell |
12,807
-8,993
| -41% | -$187K | ﹤0.01% | 2067 |
|
|
2013
Q3 | $415K | Buy |
21,800
+8,918
| +69% | +$159K | ﹤0.01% | 1890 |
|
|
2013
Q2 | $186K | Buy |
+12,882
| New | +$187K | ﹤0.01% | 2228 |
|
Other funds holding EBS
OHA
Bank of Montreal's EBS Position: Q2 2026 in Review
Bank of Montreal reduced its Emergent Biosolutions (EBS) stake by 0.01% in Q2 2026, selling an estimated $33 and leaving 27,428 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #2919.
Bank of Montreal first reported a position in EBS in Q2 2013 and has held it in 48 quarters since. The position peaked at $14.6M in Q2 2021. 180 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- Bank of Montreal held 27,428 shares of Emergent Biosolutions worth $230K as of Q2 2026.
- Bank of Montreal sold 4 Emergent Biosolutions shares in Q2 2026, an estimated $33.
- Emergent Biosolutions made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2919 holding.
- Bank of Montreal first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 48 quarters since.
- Bank of Montreal's Emergent Biosolutions position peaked at $14.6M in Q2 2021.
- 180 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.